Keyphrases
Antiretroviral Therapy
100%
AIDS Clinical Trials
100%
CD4 Lymphocyte Count
100%
Group Studies
100%
Immunogenetics
100%
Interleukin-15 (IL-15)
80%
Interleukin-2
60%
Polymorphism
40%
Tumor Necrosis Factor-α
20%
Multivariate Analysis
20%
Genotype
20%
Interleukin-7 (IL-7)
20%
Single nucleotide Polymorphism
20%
Interferon-α (IFN-α)
20%
B-cell Lymphoma 2 (Bcl-2)
20%
Genetic Variants
20%
HIV RNA
20%
CD4 Cells
20%
Multifactor Dimensionality Reduction
20%
Clinical Variables
20%
T Cell Apoptosis
20%
Interleukin
20%
Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)
20%
RNA Copies
20%
T Cell Expansion
20%
Gene-gene Interaction
20%
Complex Phenotypes
20%
Plasma Viremia
20%
Immune Recovery
20%
T Cell Survival
20%
Treatment-naïve
20%
Virologic Control
20%
Sustained Control
20%
Medicine and Dentistry
Clinical Trial
100%
Antiretroviral Therapy
100%
Immunogenetics
100%
Lymphocyte
100%
Interleukin 2
60%
Interleukin 15 Receptor
60%
Programmed Cell Death
20%
T Cell
20%
Human Immunodeficiency Virus
20%
Cytokine
20%
Tumor Necrosis Factor
20%
Interferon
20%
Single Nucleotide Polymorphism
20%
Viremia
20%
Multivariate Analysis
20%
Haplotype
20%
Study Participant
20%
Interleukin 7
20%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
20%
Immune Reconstitution
20%
Interleukin 15
20%
Gene Interaction
20%
Cell Expansion
20%
Immunology and Microbiology
CD4 Lymphocyte Count
100%
Immunogenetics
100%
Interleukin 2
75%
Interleukin-15 Receptor
75%
Blood Plasma
25%
T Cell
25%
Cytokine
25%
CD4
25%
interferon
25%
Human Immunodeficiency Virus 1
25%
Tumor Necrosis Factor
25%
Haplotype
25%
Interleukin 7
25%
Single Nucleotide Polymorphism
25%
Viremia
25%
Bcl-2
25%
Multifactor Dimensionality Reduction
25%
Interleukin 15
25%
Immune Reconstitution
25%
Interleukin
25%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
25%
Cell Expansion
25%
Gene Interaction
25%
Neuroscience
CD4
100%
Lymphocyte
100%
Interleukin 2
60%
Interleukin 15 Receptor
60%
Human Immunodeficiency Virus
20%
Haplotype
20%
T Cell
20%
Necrosis
20%
Interferon
20%
Single-Nucleotide Polymorphism
20%
Interleukin 7
20%
Bcl-2
20%
Interleukin
20%
Interleukin 15
20%
Gene Interaction
20%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
20%
Cell Expansion
20%
Blood Plasma
20%
Pharmacology, Toxicology and Pharmaceutical Science
Clinical Trial
100%
Interleukin 2
100%
Interleukin 15 Receptor
100%
HIV
33%
Cytokine
33%
Tumor Necrosis Factor
33%
Viremia
33%
Interferon
33%
Interleukin 7
33%
Tumor Necrosis Factor Related Apoptosis Inducing Ligand
33%
Interleukin 15
33%